These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease. Tincopa MA; Lyden A; Wong J; Jackson EA; Richardson C; Lok AS Dig Dis Sci; 2022 Feb; 67(2):481-491. PubMed ID: 33939147 [TBL] [Abstract][Full Text] [Related]
23. Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered. Plaz Torres MC; Aghemo A; Lleo A; Bodini G; Furnari M; Marabotto E; Miele L; Giannini EG Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817398 [TBL] [Abstract][Full Text] [Related]
24. Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial. Lim SL; Johal J; Ong KW; Han CY; Chan YH; Lee YM; Loo WM JMIR Mhealth Uhealth; 2020 Apr; 8(4):e14802. PubMed ID: 32281943 [TBL] [Abstract][Full Text] [Related]
25. Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD). Carneros D; López-Lluch G; Bustos M Nutrients; 2020 Nov; 12(11):. PubMed ID: 33198247 [TBL] [Abstract][Full Text] [Related]
26. Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Hung CK; Bodenheimer HC Clin Liver Dis; 2018 Feb; 22(1):175-187. PubMed ID: 29128055 [TBL] [Abstract][Full Text] [Related]
28. A "healthy diet-optimal sleep" lifestyle pattern is inversely associated with liver stiffness and insulin resistance in patients with nonalcoholic fatty liver disease. Katsagoni CN; Papatheodoridis GV; Papageorgiou MV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Fragopoulou E; Kontogianni MD Appl Physiol Nutr Metab; 2017 Mar; 42(3):250-256. PubMed ID: 28133993 [TBL] [Abstract][Full Text] [Related]
29. Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease. Scragg J; Hallsworth K; Taylor G; Cassidy S; Haigh L; Boyle M; Anstee Q; McPherson S; Avery L BMJ Open Gastroenterol; 2021 Jul; 8(1):. PubMed ID: 34326098 [TBL] [Abstract][Full Text] [Related]
30. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis. Hohenester S; Christiansen S; Nagel J; Wimmer R; Artmann R; Denk G; Bischoff M; Bischoff G; Rust C Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G329-G338. PubMed ID: 29878845 [TBL] [Abstract][Full Text] [Related]
31. Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis. Yoshioka N; Ishigami M; Watanabe Y; Sumi H; Doisaki M; Yamaguchi T; Ito T; Ishizu Y; Kuzuya T; Honda T; Ishikawa T; Haruta JI; Fujishiro M Sci Rep; 2020 Jan; 10(1):481. PubMed ID: 31949229 [TBL] [Abstract][Full Text] [Related]
35. The role of diet and nutrient composition in nonalcoholic Fatty liver disease. McCarthy EM; Rinella ME J Acad Nutr Diet; 2012 Mar; 112(3):401-9. PubMed ID: 22717200 [TBL] [Abstract][Full Text] [Related]
36. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis. Katsagoni CN; Georgoulis M; Papatheodoridis GV; Panagiotakos DB; Kontogianni MD Metabolism; 2017 Mar; 68():119-132. PubMed ID: 28183444 [TBL] [Abstract][Full Text] [Related]
37. Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients. Zelber-Sagi S; Bord S; Dror-Lavi G; Smith ML; Towne SD; Buch A; Webb M; Yeshua H; Nimer A; Shibolet O World J Gastroenterol; 2017 Mar; 23(10):1881-1890. PubMed ID: 28348495 [TBL] [Abstract][Full Text] [Related]
38. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. Gelli C; Tarocchi M; Abenavoli L; Di Renzo L; Galli A; De Lorenzo A World J Gastroenterol; 2017 May; 23(17):3150-3162. PubMed ID: 28533672 [TBL] [Abstract][Full Text] [Related]
39. Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment. Kim KS; Lee BW; Kim YJ; Lee DH; Cha BS; Park CY Diabetes Metab J; 2019 Apr; 43(2):127-143. PubMed ID: 30993937 [TBL] [Abstract][Full Text] [Related]
40. Managing NAFLD in Type 2 Diabetes: The Effect of Lifestyle Interventions, a Narrative Review. Parry SA; Hodson L Adv Ther; 2020 Apr; 37(4):1381-1406. PubMed ID: 32146704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]